Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

The FDA has scheduled a July 2026 meeting to review lifting compounding restrictions on seven peptides.

General Medicine

1 Posts 1 Posters 0 Views

T This user is from outside of this forum
T This user is from outside of this forum
Blaze Trends

wrote last edited by

#1

The FDA has scheduled a July 2026 meeting to review lifting compounding restrictions on seven peptides. This reverses a 2023 Biden-era policy and follows public pressure from HHS Secretary RFK Jr. #FDA #HealthNews #Medicine #Telehealth
https://blazetrends.com/fda-weighs-lifting-peptide-restrictions-inside-rfk-jrs-push-and-the-hims-stock-impact/?fsp_sid=1084
1 Reply Last reply
1
0
T #medicine shared this topic

Hello! It looks like you're interested in this conversation, but you don't have an account yet.

Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

With your input, this post could be even better 💗